Relationship-Based Intervention for Post-Partum Depression

Status Recruiting

Clinical Trial Summary

A short term dyadic psychotherapy intervention for mothers with Post-Partum depression and their babies in the first year of life was developed. The investigators believe that following dyadic intervention mothers will show improvement in depressive symptoms, the quality of the mother-child relationship will improve, and maternal and infant's oxytocin levels will rise.

Clinical Trial Description

Subjects: 60 Mothers will be interviewed and diagnosed as suffering from Post-Partum- depression (PPD) according to the Diagnostic and Statistical Manual of Mental Disorders, IV version (DSM-IV), enrolling within 3-8 months postpartum. Mothers will be recruited through social media networks. Additional 40 mothers, 3-8 months postpartum will be assessed and diagnosed as not suffering from PPD or any other psychiatric psychopathology. Procedure: The baseline assessment will be conducted at the infant's home. A parent-infant interaction will be videotaped and salivary oxytocin samples will be collected from the infant and from the mother. The women in the PPD group will participate in 8 weeks of dyadic psychotherapy (DP) combining video feedback, or a psycho-educational treatment regarding child development (randomize selection will be made). During the 8-week treatment, salivary oxytocin samples will be collected from the infants and from the mother at the beginning and the end of each session. Another assessment will be conducted at the infant's home, at the end of the treatment. As in the baseline condition, this assessment will include videotaped parent-infant interaction, as well as salivary oxytocin samples collection from the mother and from the infant. Parent-infant interaction will be filmed and assessed using the CIB Manual (Feldman, 1998) and the synchrony coding system. Healthy mothers will undergo the same baseline assessment and a second assessment within 2-3 months, and won't get any treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04193462
Study type	Interventional
Source	Interdisciplinary Center Herzliya
Contact	Moran Influs, Phd
Phone	972-545343400
Email	moran.influs@gmail.com
Status	Recruiting
Phase	N/A
Start date	May 8, 2019
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03665038` - A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)	Phase 3
Recruiting	`NCT06042972` - Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines
Completed	`NCT04813341` - Effectiveness of Mat Pilates and Aerobic Training on Fatigue and Depression	N/A
Terminated	`NCT04998565` - Add-on Effectiveness of EA or TENS in Early Postpartum Breast Engorgement	N/A
Completed	`NCT04135612` - The Impact of a Daily Smartphone-based Communication Among Postpartum Women on Breastfeeding Rates	N/A
Recruiting	`NCT05595486` - Baby2Home (B2H) Mobile Health Application	N/A
Not yet recruiting	`NCT04516668` - Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression
Completed	`NCT05215028` - Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study
Recruiting	`NCT04129476` - Effect of a Cooperative Education Program Based on Precede-Proceed Model During Pregnancy on Postpartum Depression	N/A
Completed	`NCT03638687` - Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers
Active, not recruiting	`NCT03052374` - Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS")	N/A
Active, not recruiting	`NCT04940585` - ROSE in Sunset Park	N/A
Terminated	`NCT04011592` - Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression	Phase 2
Recruiting	`NCT05887115` - Nurse Family Partnership for Women With Previous Live Births	N/A
Completed	`NCT04818047` - Adaptation and Pilot Testing of Web and Mobile Interface for the VID-KIDS Intervention	N/A
Not yet recruiting	`NCT05643898` - "Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women	N/A
Terminated	`NCT04264520` - Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women	N/A
Recruiting	`NCT04845347` - A Wearable Morning Light Treatment for Postpartum Depression	N/A
Not yet recruiting	`NCT06253676` - Sensing Technologies for Maternal Depression Treatment in Low-Resource Settings	N/A
Enrolling by invitation	`NCT05186272` - mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.